Power Law company profile

Nerio Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Patent intelligence

$161k patent portfolio · 8 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$161k

0.01% of valuation · 112.7× smaller than top peer PMV Pharmaceuticals ($18M)

8 active patent families

Where Nerio Therapeutics innovates CarcinosisMolecular biologyTyrosinePTPN1Cancer research

Above peer median on Strategic · Below peer median on Legal, Market

Quality vs same-sector peers

Nerio Therapeutics on the five Patsnap quality dimensions

Nerio Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Nerio Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Nerio Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Nerio Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo